H19 and diabetes mellitus: An extracellular vesicle-mimetic nanovesicle containing lncRNA-H19 is considered an effective treatment that could remarkably accelerate the healing processes of chronic wounds induced by diabetes [107], indicating that noncoding RNA-containing exosomes can be a promising candidate for drug delivery.